A set of guidelines regarding the use of multimodality cardiovascular (CV) imaging in young adult competitive athletes, focusing on the distinction between exercise-induced cardiac remodeling (EICR) and cardiac pathology, was formulated by an expert writing group and published in the Journal of the American Society of Echocardiography.
This report was endorsed by the American Society of Echocardiography, in conjunction with the Society of CV Computed Tomography (CT) and the Society for CV Magnetic Resonance (CMR).
Young competitive athletes with unrecognized CV disease (CVD) who undergo strenuous exercise may be at increased risk for serious adverse events, including sudden cardiac death. Expertise in and appropriate utilization of multimodality CV imaging techniques including transthoracic echocardiography (TTE), CT angiography (CTA) and CMR are essential in order to ensure proper diagnosis, risk stratification and ruling out of CVD in this population, as well as for the clinical management of detected pathologies. This requires selection of the appropriate imaging modality, high-quality performance of the imaging technique, as well as accurate interpretation, which demands an in-depth comprehension of EICR which may be modified in young athletes by physiological adaption, and should not be misinterpreted (ie, as resulting from pathophysiology). Cardiac specialists with training in these areas are in an ideal position to provide competitive athletes with comprehensive care.
In most cases in which CVD is suspected or confirmed, initial imaging studies should involve TTE 2-dimensional or Doppler with CTA or CMR follow-up as needed. The advantages of TTE include low cost and high availability, and the fact that this technique can readily be used to characterize myocardial structure, valve and proximal coronary anatomy and physiology, as well as systolic and diastolic function. The use of CMR is especially helpful when investigating potential myocardial pathology, particularly right ventricular (RV) and aortic morphology and function, but its use is limited by high cost and limited accessibility, as well as contraindications in individuals with metal implants. In certain clinical situations, CTA may be ideal, such as when the anatomy of the great vessels or the proximal coronary structures must be precisely defined. However, exposure to ionizing radiation remains a concern.
The imaging specialists who conduct and/or interpret the results of competitive athletes should understand the fundamentals of exercise physiology and EICR. Regarding left ventricular (LV) adaptations in this population, a multifactorial and complex influence of sex, ethnicity, duration of prior exercise, and type of sport determines both the geometry (eccentric vs concentric) and magnitude (chamber volumes/dimensions and absolute wall thickness) of EICR changes. When RV dilation, which is common in endurance athletes, occurs secondary to EICR, there should be concomitant biatrial dilation and eccentric LV hypertrophy/remodeling. It is not uncommon for athletes to have mild aortic dilation. In cases in which absolute aorta measurements exceed 34 mm and 40 mm in women and men, respectively, an initial TTE should be followed by CMR or gated CTA.
The distinction between EICR and pathology demands careful measurement of parasternal long-axis view of LV wall thickness to avoid inclusion of RV chordal tissue and septal trabeculations. There is generally mild LV wall thickening with EICR that varies slightly based on race, and measurements above cutoffs may indicate pathology. Pathologic LV remodeling should be suspected in any patient with LV wall thickening accompanied by indicators of reduced diastolic function and/or longitudinal systolic strain. Incomplete TTE LV visualization or uncertain etiology of thickening should be followed up with CMR.
When LV dilation is suspected on TTE, confirmatory CMR should be performed to better characterize chamber structure and function, with distinction between EICR and pathology requiring integration of the patients history and additional testing results rather than simple assessment of LV or left atrial dilation magnitude. Mild reductions in LV ejection fraction (by 45-55%) that occur alongside RV and biatrial dilation without diastolic dysfunction should be considered as a result of physiologic adaptation.
When RV dilation is detected on TTE without clear etiology, CMR should be performed. Endurance athletes often have RV dilation that is accompanied by LV dilation, and in the absence of structural or functional abnormalities, this adaptation should be considered physiologic. However, isolated clinical cutoffs normally used to indicate RV dilation cannot differentiate EICR from pathology in competitive athletes.
Although physiologic hypertrabeculation of the LV apex is common among competitive athletes, particularly in black and/or endurance competitors, this feature needs tobe distinguished from noncompaction cardiomyopathy. When hypertrabeculation is seen in the context of abnormal LV wall thickness or systolic/diastolic dysfunction and cardiomyopathy is suspected, incomplete TTE visualization of the area should be followed by CMR imaging.
Young adult competitive athletes should undergo a CV screening prior to engaging in sports. This screening should include a focused history and physical exam and may incorporate a 12-lead electrocardiogram. Although TTE, CTA and CMR are not recommended as part of this initial screening, those responsible for such programs must be closely connected to medical centers staffed with sports cardiologists and imaging experts, in order to further evaluate any abnormal findings detected during the process.
In athletes who present with chest pain, TTE should be used as a first-line strategy for investigation, followed by maximal effort-limited (not heart rate[HR]-limited) exercise testing with immediate post-exercise TTE before HR recovery can occur. Anomalous coronary vasculature should be excluded through careful examination of the origins and proximal course of the left and right coronary circulation. If this cannot be accomplished using TTE, CTA or CMR should be performed to clarify coronary anatomy.
Neurally mediated syncope that occurs following exercise or that is unrelated to strenuous effort is common among competitive athletes and does not require evaluation with noninvasive imaging studies. However, when the etiology of syncope is uncertain, and especially when it occurs during exercise, comprehensive assessment is necessary. This evaluation should involve TTE, followed by CTA or CMR, in order to rule out structural or valvular disease. In addition, maximal effort-limited exercise testing should be performed.
Athletes who report palpitations that begin or intensify during strenuous activity should undergo TTE initially to look for structural disease. This should be followed in some cases (based on presentation and TTE findings), by CMR. Maximal effort-limited exercise testing with or without imaging should also be performed in these patients. In individuals evaluated for symptomatic or asymptomatic ventricular pre-excitation, TTE can exclude complex congenital heart disease, PRKAG2 gene-mediated hypertrophic cardiomyopathy, and Ebsteins anomaly.
When a young athlete presents with inappropriate exertional dyspnea, either as a new sign or an indicator of nonresponsiveness to therapy for a previously identified noncardiac cause, a TTE should be performed. This should be followed by maximal effort-limited exercise testing with or without imaging.
Finally, when an athlete reports a decline in performance and his or her initial evaluation suggests possible coronary, myocardial or valvular pathology (or when there is no clear explanation for this change), TTE should be performed. Clinical suspicions should help determine the addition of CTA, CMR and/or exercise testing.
Additional recommendations briefly addressed the evaluation of slightly older competitive athletes, pediatric athletes, and those with congenital heart disease.
Differentiating EICRfrom mild forms of pathology remains challenging in clinical practice and corollary data in specific groups, including children and people with congenital heart disease, are sparse. Further acquisition of normative data, particularly data derived from CMR and CTA, may further address these important contemporary clinical challenges, noted the authors.
Conflicts of Interest Disclosures
The following authors reported relationships with one or more commercial interests: Pamela S Douglas, MD, FASE owns stock in UpToDate/Kluwer and is DSMB for REAL TIMI 63B; Christopher M Kramer, MD received grant support from Regeneron and is a consultant for Cytokinetics; Eric Williamson, MD is an unpaid consultant for Siemens Medical and is the recipient of an investigator-initiated research grant from GE Healthcare.
Reference
Baggish AL, Battle RW, Beaver TA, et al. Recommendations on the use of multimodality cardiovascular imaging in young adult competitive athletes: a report from the American Society of Echocardiography in collaboration with the Society of Cardiovascular Computed Tomography and the Society for Card. J Am Soc Echocardiogr. 2020;33(5):523-549. doi:10.1016/j.echo.2020.02.009
Original post:
Multi-Society Guidelines on the Use of Multimodality CV Imaging in Competitive Athletes - The Cardiology Advisor
- Managing Right Ventricular Failure in PAH: An Algorithmic Approach | Advances in ... [Last Updated On: April 13th, 2018] [Originally Added On: April 13th, 2018]
- What Is the Ejection Fraction? - Verywell Health [Last Updated On: May 12th, 2018] [Originally Added On: May 12th, 2018]
- Ventricular septal defect - Wikipedia [Last Updated On: June 21st, 2018] [Originally Added On: June 21st, 2018]
- Heart Failure Medication: Beta-Blockers, Alpha Activity ... [Last Updated On: July 7th, 2018] [Originally Added On: July 7th, 2018]
- Acute Management of Pulmonary Embolism - American College ... [Last Updated On: July 17th, 2018] [Originally Added On: July 17th, 2018]
- Ventricular Remodeling | Profiles RNS [Last Updated On: July 24th, 2018] [Originally Added On: July 24th, 2018]
- Left ventricular hypertrophy - Wikipedia [Last Updated On: August 20th, 2018] [Originally Added On: August 20th, 2018]
- Ventricular Remodeling Surgery (SVR) [Last Updated On: September 24th, 2018] [Originally Added On: September 24th, 2018]
- Left Ventricular Remodeling in Heart Failure | JACC ... [Last Updated On: November 25th, 2018] [Originally Added On: November 25th, 2018]
- Ventricular dysfunction in heart failure - Britannica.com [Last Updated On: December 25th, 2018] [Originally Added On: December 25th, 2018]
- TIMI Study Group - LEADERSHIP [Last Updated On: January 31st, 2019] [Originally Added On: January 31st, 2019]
- Ventricular Remodeling Procedure | Main Line Health ... [Last Updated On: February 24th, 2019] [Originally Added On: February 24th, 2019]
- BioLineRx Ltd. (BLRX)'s Financial Results Comparing With Coherus BioSciences Inc. (NASDAQ:CHRS) - Stocks Beat [Last Updated On: September 18th, 2019] [Originally Added On: September 18th, 2019]
- Reviewing Aeterna Zentaris Inc. (AEZS)'s and BioLineRx Ltd. (NASDAQ:BLRX)'s results - Stocks Beat [Last Updated On: September 18th, 2019] [Originally Added On: September 18th, 2019]
- Karuna Therapeutics Inc. (KRTX) and BioLineRx Ltd. (NASDAQ:BLRX) Comparing side by side - Stocks Beat [Last Updated On: September 18th, 2019] [Originally Added On: September 18th, 2019]
- Arbutus Biopharma Corporation (ABUS)'s Financial Results Comparing With BioLineRx Ltd. (NASDAQ:BLRX) - The EN Herald [Last Updated On: September 18th, 2019] [Originally Added On: September 18th, 2019]
- Cardiac Dimensions touts Carillon TMVR study - Mass Device [Last Updated On: September 18th, 2019] [Originally Added On: September 18th, 2019]
- New PROVE-HF Data May Reassure Clinicians of Sacubitril/Valsartan Benefit in HFrEF - TCTMD [Last Updated On: September 18th, 2019] [Originally Added On: September 18th, 2019]
- Cardiac Restoration Systems Market Will Make a Huge Impact in Near Future - Wolf Mirror [Last Updated On: September 18th, 2019] [Originally Added On: September 18th, 2019]
- Reduce Fmr Study Shows Cardiac Dimensions' Carillon System Significantly Improves Mitral Regurgitation And Slows Worsening Of Heart Failure - TCTMD [Last Updated On: September 18th, 2019] [Originally Added On: September 18th, 2019]
- Heart Failure Society of America 2019: Virtual Visits, Spironolactone Issues, and Reasons to Worry - DocWire News [Last Updated On: September 18th, 2019] [Originally Added On: September 18th, 2019]
- LV Reverse Remodeling Not Improved by SGLT-2 Inhibitor - DocWire News [Last Updated On: September 18th, 2019] [Originally Added On: September 18th, 2019]
- BioLineRx Ltd. (BLRX)'s Financial Results Comparing With Soligenix Inc. (NASDAQ:SNGX) - CryptoCoinsTribune [Last Updated On: September 22nd, 2019] [Originally Added On: September 22nd, 2019]
- Biolinerx LTD. American Depositary Shares (NASDAQ:BLRX) Could Burn Your Long Portfolio After More Shorts - The MAK Daily [Last Updated On: September 22nd, 2019] [Originally Added On: September 22nd, 2019]
- Reviewing BioLineRx Ltd. (BLRX)'s and Dicerna Pharmaceuticals Inc. (NASDAQ:DRNA)'s results - CryptoCoinsTribune [Last Updated On: September 22nd, 2019] [Originally Added On: September 22nd, 2019]
- Comparison of Protalix BioTherapeutics Inc. (PLX) and BioLineRx Ltd. (NASDAQ:BLRX) - MS Wkly [Last Updated On: October 19th, 2019] [Originally Added On: October 19th, 2019]
- Contrasting of BioLineRx Ltd. (BLRX) and Edge Therapeutics Inc. (:) - MS Wkly [Last Updated On: October 19th, 2019] [Originally Added On: October 19th, 2019]
- Contrasting of BioLineRx Ltd. (BLRX) and Protalix BioTherapeutics Inc. (NYSEAMERICAN:PLX) - The Broch Herald [Last Updated On: November 7th, 2019] [Originally Added On: November 7th, 2019]
- BioLineRx Ltd. (BLRX)'s Financial Results Comparing With Cyanotech Corporation (NASDAQ:CYAN) - The Broch Herald [Last Updated On: November 7th, 2019] [Originally Added On: November 7th, 2019]
- Triple-Gene Announces Completion of Enrollment and Dosing in Phase 1 Trial of INXN-4001, First Multigenic Investigational Therapeutic Candidate for... [Last Updated On: November 7th, 2019] [Originally Added On: November 7th, 2019]
- Contrasting of BioLineRx Ltd. (BLRX) and Moderna Inc. (NASDAQ:MRNA) - The Broch Herald [Last Updated On: December 3rd, 2019] [Originally Added On: December 3rd, 2019]
- Edited Transcript of MYOK earnings conference call or presentation 11-Nov-19 1:30pm GMT - Yahoo Finance [Last Updated On: December 3rd, 2019] [Originally Added On: December 3rd, 2019]
- Cardiac Restoration Systems Market: Key Growth Factors and Industry Analysis 2018 - 2028 - The Market Expedition [Last Updated On: December 3rd, 2019] [Originally Added On: December 3rd, 2019]
- Velocity Transfer Function In The Right Pulmonary Artery And Impaired | COPD - Dove Medical Press [Last Updated On: December 3rd, 2019] [Originally Added On: December 3rd, 2019]
- 3 Stocks to Buy Ahead of the Next Market Crash - The Motley Fool [Last Updated On: December 3rd, 2019] [Originally Added On: December 3rd, 2019]
- Pulmonary Hypertension, Common in TAVR Patients, Linked to Lower Survival - TCTMD [Last Updated On: December 3rd, 2019] [Originally Added On: December 3rd, 2019]
- Patients With Chemotherapy-Induced Cardiomyopathy Show Improvements in LVEF After Cardiac Resynchronization Therapy - AJMC.com Managed Markets Network [Last Updated On: December 4th, 2019] [Originally Added On: December 4th, 2019]
- BioVentrix Announces Publication of Positive One-Year Outcomes for Revivent TC System - Yahoo Finance [Last Updated On: December 4th, 2019] [Originally Added On: December 4th, 2019]
- Cardiac Restoration Systems Market Forecasted To Surpass The Value Of US$ XX Mn/Bn By 2055 2017 2025 - Weekly News Times [Last Updated On: December 13th, 2019] [Originally Added On: December 13th, 2019]
- The Outer Line: The impact of endurance training on the cardiac health of women - VeloNews [Last Updated On: December 13th, 2019] [Originally Added On: December 13th, 2019]
- Contrasting of Insmed Incorporated (INSM) and BioLineRx Ltd. (NASDAQ:BLRX) - The CoinGlobalist [Last Updated On: December 16th, 2019] [Originally Added On: December 16th, 2019]
- CARDIAC RESTORATION SYSTEMS MARKET ANALYSIS TRENDS, GROWTH OPPORTUNITIES, SIZE, TYPE, DYNAMIC DEMAND AND DRIVES WITH FORECASTS TO 2028 - Voice of... [Last Updated On: January 13th, 2020] [Originally Added On: January 13th, 2020]
- Early Expressed Circulating Long Noncoding RNA CHAST is Associated with Cardiac Contractile Function in Patients with Acute Myocardial Infarction -... [Last Updated On: January 13th, 2020] [Originally Added On: January 13th, 2020]
- Clinical Phenogroups in Heart Failure With Preserved Ejection Fraction: Detailed Phenotypes, Prognosis, and Response to Spironolactone - DocWire News [Last Updated On: January 23rd, 2020] [Originally Added On: January 23rd, 2020]
- Increased Long-Term Risk for Venous Thromboembolism After Heart Failure - The Cardiology Advisor [Last Updated On: January 23rd, 2020] [Originally Added On: January 23rd, 2020]
- Retinoid X receptor alpha is a spatiotemporally predominant therapeutic target for anthracycline-induced cardiotoxicity - Science Advances [Last Updated On: February 1st, 2020] [Originally Added On: February 1st, 2020]
- Coronary Microvascular Dysfunction Found to Increase Risk for CV Events in Chronic Kidney Disease - The Cardiology Advisor [Last Updated On: February 1st, 2020] [Originally Added On: February 1st, 2020]
- New Data Confirms Cardiac Dimensions' Carillon System Shows Favorable Long-Term Survival Rate In Patients With Functional Mitral Regurgitation -... [Last Updated On: February 26th, 2020] [Originally Added On: February 26th, 2020]
- BioVentrix Announces Ralph Stephan von Bardeleben, MD, as Co- Principal Investigator of the REVIVE-HF Clinical Trial - Yahoo Finance [Last Updated On: March 5th, 2020] [Originally Added On: March 5th, 2020]
- Relationship between histopathological features of aspirated thrombi and long-term left ventricular function in patients with ST-segment elevation... [Last Updated On: March 15th, 2020] [Originally Added On: March 15th, 2020]
- FierceMedTech Names BioVentrix as One of Its "Fierce 15" Companies of 2019 - Yahoo Finance [Last Updated On: March 15th, 2020] [Originally Added On: March 15th, 2020]
- Causes and Prevention of Ventricular Remodeling After MI ... [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Left Ventricular Remodelling - ECR Journal [Last Updated On: April 23rd, 2020] [Originally Added On: April 23rd, 2020]
- Cardiac Restoration Systems Market to Make Great Impact in Near Future by 2026 - The Canton Independent Sentinel [Last Updated On: June 12th, 2020] [Originally Added On: June 12th, 2020]
- Chronic PDE5i Treatment Found to Improve Cardiac Remodeling in Men, but Not Women, With Diabetic Cardiomyopathy - Endocrinology Advisor [Last Updated On: June 12th, 2020] [Originally Added On: June 12th, 2020]
- Acceleron to Host Conference Call and Webcast to Review Results of PULSAR Phase 2 Trial of Sotatercept Presented at American Thoracic Society 2020... [Last Updated On: June 23rd, 2020] [Originally Added On: June 23rd, 2020]
- American Heart Association and Barth Syndrome Foundation Partner to Address Rare Disease - PR Web [Last Updated On: August 29th, 2020] [Originally Added On: August 29th, 2020]
- The Association of Cardio-Ankle Vascular Index (CAVI) with Biatrial Remodeling in Atrial Fibrillation - DocWire News [Last Updated On: September 3rd, 2020] [Originally Added On: September 3rd, 2020]
- Cardiac Dimensions Announces Australian Therapeutic Goods Administration's Approval of the Carillon System for the Treatment of Functional Mitral... [Last Updated On: September 3rd, 2020] [Originally Added On: September 3rd, 2020]
- Sep 4 2020 This Week in Cardiology - Medscape [Last Updated On: September 5th, 2020] [Originally Added On: September 5th, 2020]
- Emerging treatment helps reverse heart failure in some patients - Science Codex [Last Updated On: October 27th, 2020] [Originally Added On: October 27th, 2020]
- GMAX Biopharm gives first does of anti-body drug treating PAH in phase 1B trial - PRNewswire [Last Updated On: October 27th, 2020] [Originally Added On: October 27th, 2020]
- North America to Outshine the Global Slowdown in Cardiac Restoration Systems market between 2020 and 2030 - The Think Curiouser [Last Updated On: November 12th, 2020] [Originally Added On: November 12th, 2020]
- Age-Related Development of Cardiac Remodeling and Dysfunction in Young Black and White Adults: the Coronary Artery Risk Development in Young Adults... [Last Updated On: November 25th, 2020] [Originally Added On: November 25th, 2020]
- Adiponectin receptor 1 variants contribute to hypertrophic cardiomyopathy that can be reversed by rapamycin - Science Advances [Last Updated On: January 13th, 2021] [Originally Added On: January 13th, 2021]
- Longer Survival Seen in Heart Failure Stabilized Via Cardiac Resynchronization Therapy - The Cardiology Advisor [Last Updated On: April 13th, 2021] [Originally Added On: April 13th, 2021]
- Cardiac Dimensions Welcomes Robert White to its Board of Directors - PRNewswire [Last Updated On: April 13th, 2021] [Originally Added On: April 13th, 2021]
- [Full text] SIRT1 is Required for Exercise-Induced Beneficial Effects on Myocardia | JIR - Dove Medical Press [Last Updated On: April 13th, 2021] [Originally Added On: April 13th, 2021]
- Role of Pyroptosis in Diabetes and Its Therapeutic Implications | JIR - Dove Medical Press [Last Updated On: May 25th, 2021] [Originally Added On: May 25th, 2021]
- Epigenetic therapies for heart failure | VHRM - Dove Medical Press [Last Updated On: May 25th, 2021] [Originally Added On: May 25th, 2021]
- Are you at risk for sudden death, and can it be prevented? - Jamaica Observer [Last Updated On: May 25th, 2021] [Originally Added On: May 25th, 2021]
- Does a plant-based diet improve cardiac function? Here's the answer - Hindustan Times [Last Updated On: June 21st, 2021] [Originally Added On: June 21st, 2021]
- Early Use of Sacubitril/Valsartan Linked to Improved Cardiac Function Post AMI - AJMC.com Managed Markets Network [Last Updated On: November 5th, 2021] [Originally Added On: November 5th, 2021]
- Higher BP, LV Changes Seen in Children Conceived by ART - Medscape [Last Updated On: November 5th, 2021] [Originally Added On: November 5th, 2021]
- Regional Heterogeneity in Determinants of Atrial Matrix Remodeling and Association with Atrial Fibrillation Vulnerability Post-Myocardial Infarction -... [Last Updated On: January 26th, 2022] [Originally Added On: January 26th, 2022]
- 4 promising heart failure therapies interventional cardiologists should keep an eye on - Cardiovascular Business [Last Updated On: May 7th, 2022] [Originally Added On: May 7th, 2022]
- LEXEO Therapeutics Announces Data Presentations at the 25th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting - Yahoo Finance [Last Updated On: May 7th, 2022] [Originally Added On: May 7th, 2022]
- Ventricular structure and function in hypertensive patients | IJGM - Dove Medical Press [Last Updated On: May 7th, 2022] [Originally Added On: May 7th, 2022]
- Effects of diabetes mellitus on left ventricular function and remodeling in hypertensive patients with heart failure with reduced ejection fraction:... [Last Updated On: May 7th, 2022] [Originally Added On: May 7th, 2022]
- Cardior Announces CE Marking of CardiorHealth miR-132 PCR Kit Used in Ongoing HF-REVERT Phase 2 Clinical Study - Business Wire [Last Updated On: September 12th, 2022] [Originally Added On: September 12th, 2022]